Sort   by:  
 Page size 
UnknownRandomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
Not available
S-EPMC3970172 | biostudies-literature
UnknownVariants in HCFC1 and MN1 genes causing intellectual disability in two Pakistani families.
Not available
S-EPMC11221130 | biostudies-literature
UnknownThe Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials.
Not available
S-EPMC8657254 | biostudies-literature
UnknownStructural and functional implications of SLC13A3 and SLC9A6 mutations: an in silico approach to understanding intellectual disability.
Not available
S-EPMC10548666 | biostudies-literature
UnknownEfficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
Not available
S-EPMC10911916 | biostudies-literature
UnknownPharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer.
Not available
S-EPMC9081826 | biostudies-literature
UnknownImpact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials.
Not available
S-EPMC9184276 | biostudies-literature
UnknownEpidemiology and outcomes of out of hospital cardiac arrest in Karachi, Pakistan - A longitudinal study.
Not available
S-EPMC11417593 | biostudies-literature
UnknownCurrent Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver Disease.
Not available
S-EPMC12055015 | biostudies-literature
UnknownDarolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.
Not available
S-EPMC11552649 | biostudies-literature
Sort   by:  
 Page size